Google
Trusted Resources: News & Events
Latest announcements and gatherings
Study Suggests Ways of Improving Newborn Screening for Sickle Cell Disease
Researchers in Spain have defined cutoff points in hemoglobin measuring that can improve sensitivity and specificity to neonatal screening for sickle cell disease (SCD). Scientists can apply the method to diagnose other blood disorders, leading to better neonatal care.
Their report, “Impact of prematurity and immigration on neonatal screening for sickle cell disease,” appeared in the scientific journal PLOS One.
Measuring levels of different hemoglobins in infants is essential in diagnosing SCD. Previous research had described the relationship among hemoglobin A levels, the duration of the pregnancy, the baby’s gender and the mother’s ethnicity. However, those studies never defined normal cutoff points for different neonatal hemoglobins that took such factors into account, thereby compromising the sensitivity of these diagnostic tests.
+myBinderRelated Content
-
MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-m...Hematopoietic stem cell transplant for s...
-
Sickle Cell DiseaseSickle cell disease changes normal, roun...
-
Sickle cell disease, sickle trait and the risk for venous thromboembolism: A systematic review and meta-analysisBackground: Globally, sickle cell disea...
-
Sickle cell trait may not increase the risk of deathPeople who carry a gene for sickle cell ...
-
Sickle Cell Disease: All you Need to KnowSickle cell disease (SCD) is an inherite...
-
Gene Therapy for Blood DisordersIn the context of intense scrutiny over ...
-
MARAC Statement: Crizanlizumab (Adakveo)July 7, 2023 - SCDAA’s Medical and Res...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.